Published in Analyst on October 07, 2015
Bone marrow stromal/stem cell-derived extracellular vesicles regulate osteoblast activity and differentiation in vitro and promote bone regeneration in vivo. Sci Rep (2016) 0.78
Emerging applications of exosomes in cancer therapeutics and diagnostics. Bioeng Transl Med (2017) 0.75
Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification. PLoS One (2017) 0.75
Melanoma exosomes deliver a complex biological payload that upregulates PTPN11 to suppress T lymphocyte function. Pigment Cell Melanoma Res (2016) 0.75
Effects of storage temperature on airway exosome integrity for diagnostic and functional analyses. J Extracell Vesicles (2017) 0.75
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol (2008) 19.86
Membrane vesicles as conveyors of immune responses. Nat Rev Immunol (2009) 14.72
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol (2008) 11.46
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med (2012) 11.14
Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol (2013) 10.02
Shedding microvesicles: artefacts no more. Trends Cell Biol (2009) 8.84
Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol (2008) 7.30
Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A (2010) 6.72
Exosomes: extracellular organelles important in intercellular communication. J Proteomics (2010) 6.47
Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia (2006) 6.45
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med (2001) 5.71
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci (2011) 5.42
Malignant effusions and immunogenic tumour-derived exosomes. Lancet (2002) 4.91
Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol (1983) 4.64
Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 4.35
Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun (2011) 4.07
Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol (2007) 3.75
Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res (2011) 3.73
Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol (1985) 3.63
Regulation of immune responses by extracellular vesicles. Nat Rev Immunol (2014) 3.24
Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ (2007) 3.22
The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol (2011) 2.83
Active Wnt proteins are secreted on exosomes. Nat Cell Biol (2012) 2.81
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer (2009) 2.76
Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res (2010) 2.62
Human tumor-derived exosomes down-modulate NKG2D expression. J Immunol (2008) 2.53
Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell (2014) 2.41
Single vs. swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost (2012) 2.39
Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces (2011) 2.38
Optical and non-optical methods for detection and characterization of microparticles and exosomes. J Thromb Haemost (2010) 2.19
Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br J Cancer (2005) 2.17
Can urinary exosomes act as treatment response markers in prostate cancer? J Transl Med (2009) 2.14
Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med (2011) 2.10
MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity (2014) 1.95
Amphiregulin exosomes increase cancer cell invasion. Curr Biol (2011) 1.93
Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry. Nat Protoc (2012) 1.71
Paracrine induction of endothelium by tumor exosomes. Lab Invest (2009) 1.63
Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells. J Extracell Vesicles (2012) 1.52
Engineering synthetic vaccines using cues from natural immunity. Nat Mater (2013) 1.48
Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol (2012) 1.46
Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles. Nanomedicine (2011) 1.37
Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. Oncogene (2014) 1.33
Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL. J Immunol (2007) 1.32
Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. ACS Nano (2010) 1.32
More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells. Clin Cancer Res (2005) 1.29
Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates. ACS Nano (2012) 1.23
Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. Cancer Res (2013) 1.19
Exosomes in tumour immunity. Curr Oncol (2009) 1.10
Exosomes secreted by human cells transport largely mRNA fragments that are enriched in the 3'-untranslated regions. Biol Direct (2013) 1.06
Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics. J Control Release (2014) 1.05
The role of exosomes and microRNAs in senescence and aging. Adv Drug Deliv Rev (2012) 0.97
Melanoma exosomes: messengers of metastasis. Nat Med (2012) 0.96
Scalable analysis of flow cytometry data using R/Bioconductor. Cytometry A (2009) 0.95
High-resolution immunogold localization of Giardia cyst wall antigens using field emission SEM with secondary and backscatter electron imaging. J Histochem Cytochem (1990) 0.91
Exosomes function in cell-cell communication during brain circuit development. Curr Opin Neurobiol (2013) 0.86
Inferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models. Biotechnol Bioeng (2014) 0.84
Anticancer properties of 10-hydroxycamptothecin in a murine melanoma pulmonary metastasis model in vitro and in vivo. Toxicol In Vitro (2010) 0.84
A quantitative systems approach to identify paracrine mechanisms that locally suppress immune response to Interleukin-12 in the B16 melanoma model. Integr Biol (Camb) (2012) 0.84
Localization of MOC-1 cell surface antigen in small-cell lung carcinoma cell lines: an immunohistochemical and immunoelectron microscopic study. J Histochem Cytochem (1993) 0.80
Simultaneous delivery of an active protein and neutralizing antibody: creation of separated regions of biological activity. J Control Release (2001) 0.80
Protein-based identification of quantitative trait loci associated with malignant transformation in two HER2+ cellular models of breast cancer. Proteome Sci (2012) 0.78
AAV-mediated gene therapy for retinal degeneration in the rd10 mouse containing a recessive PDEbeta mutation. Invest Ophthalmol Vis Sci (2008) 1.68
Achromatopsia as a potential candidate for gene therapy. Adv Exp Med Biol (2010) 1.06
Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid. Cancer Biol Ther (2009) 1.03
Mitogen-activated protein kinases activate the nuclear localization sequence of human papillomavirus type 11 E1 DNA helicase to promote efficient nuclear import. J Virol (2007) 1.01
Identification and classification of bcl genes and proteins of Bacillus cereus group organisms and their application in Bacillus anthracis detection and fingerprinting. Appl Environ Microbiol (2009) 0.91
Inferring relevant control mechanisms for interleukin-12 signaling in naïve CD4+ T cells. Immunol Cell Biol (2010) 0.91
Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling. BMC Cancer (2010) 0.90
A quantitative systems approach to identify paracrine mechanisms that locally suppress immune response to Interleukin-12 in the B16 melanoma model. Integr Biol (Camb) (2012) 0.84
Protein-based identification of quantitative trait loci associated with malignant transformation in two HER2+ cellular models of breast cancer. Proteome Sci (2012) 0.78
Graphene ultracapacitors: structural impacts. Phys Chem Chem Phys (2013) 0.78
Correlation study of chronic nonbacterial prostatitis with the levels of COX-2 and PGE2 in prostatic secretion. Int Urol Nephrol (2014) 0.77
Quantifying spontaneous metastasis in a syngeneic mouse melanoma model using real time PCR. Analyst (2017) 0.75
Polymerization of low molecular weight hydrogelators to form electrochromic polymers. Chem Commun (Camb) (2015) 0.75